InChI=1S/C20H26O6/c1- 6- 10(2) 18(22) 25- 15- 9- 20(5) 16(26- 20) 8- 13(21) 11(3) 7- 14- 17(15) 12(4) 19(23) 24- 14/h6- 7,13- 17,21H,4,8- 9H2,1- 3,5H3/b10- 6+,11- 7+/t13- ,14- ,15- ,16- ,17+,20- /m1/s1 |
DZTWAOVNNLDWNH-DRCJWTCISA-N |
[H][C@@]12C[C@@H](O)\C(C)=C\[C@@]3([H])OC(=O)C(=C)[C@]3([H])[C@@H](C[C@@]1(C)O2)OC(=O)C(\C)=C\C |
|
Eupatorium kiirunense
(IPNI:1009045-1)
|
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1aR,3R,4E,5aR,8aR,9R,10aR)- 3- hydroxy- 4,10a- dimethyl- 8- methylidene- 7- oxo- 1a,2,3,5a,7,8,8a,9,10,10a- decahydrooxireno[5,6]cyclodeca[1,2- b]furan- 9- yl (2E)- 2- methylbut- 2- enoate
|
10-epoxy-6βH,7αH-helianga-4Z,11(13)-dien-6,12-olide
|
ChEBI
|
8β- tigloyloxy- 3α- hydroxy- 1α,10- epoxy- 6βH,7αH- helianga- 4Z,11(13)- dien- 6,12- olide
|
ChEBI
|
11258336
|
Reaxys Registry Number
|
Reaxys
|
15921421
|
PubMed citation
|
Europe PMC
|
|